Avalon Globocare Corp (ALBT)

Avalon GloboCare Corp. is a common stock listing on NASDAQ tied to Avalon GloboCare Corp., a company active in real estate and related operations in the United States. Through its subsidiaries, the company owns and operates commercial properties and also has activities outside property ownership, including the distribution of the KetoAir breathalyzer system, which measures acetone in exhaled breath, and the AI Nutritionist software program for ketogenic diet monitoring and management. The company was founded in 2015 and is based in Freehold, New Jersey.


Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Overall Financial Health Dividend Yield Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Free Cash Flow / Net Income
NASDAQ-ALBT
$0.21
-29.1% Downside
Overvalued
Not available
Not available
Weak
0.0%
3.448 M
31.13 M
4.5%
89.5%
-101.5
31.5%
Valuation • Fair Value

Avalon Globocare Corp (NASDAQ-ALBT) Fair Value by Valuation Model

Review the available estimates for Avalon Globocare Corp (NASDAQ-ALBT), including Comps Fair Value.

Primary Valuation Read

Fair Value

$0.21

Estimated downside of 29.1% versus the current market price.

Fair Value Confidence

Low

Confidence level for the primary fair value estimate.

Comps Fair Value

$0.21

Comparable-company valuation reference.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

Use the 3 available valuation references for Avalon Globocare Corp (NASDAQ-ALBT) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for Avalon Globocare Corp (NASDAQ-ALBT)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

0 K

Current operating scale indicator.

Revenue Forecast

392.677 K

Forward revenue estimate.

EBITDA

-7.87 M

Current operating profitability reference.

How to read profitability and growth

This section helps investors review Avalon Globocare Corp (NASDAQ-ALBT) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Avalon Globocare Corp (NASDAQ-ALBT)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Weak

Financial pressure deserves closer review.

Piotroski Score

3

Weak quality score that deserves closer review.

Altman Z-Score

-101.5

Lower score that deserves closer risk review.

FCF / Net Income

31.5%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Avalon Globocare Corp (NASDAQ-ALBT). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Dividend Profile for Avalon Globocare Corp (NASDAQ-ALBT)

Review the dividend metrics currently supported by the latest data.

Dividend Yield

0.0%

No current dividend yield is indicated.

How to read events and dividends

The latest data indicates no current dividend yield for Avalon Globocare Corp (NASDAQ-ALBT). No upcoming dividend amount or event date is currently available.

Technical Outlook

Technical Signals by Time Frame

Review the technical signals currently available for this stock across supported time frames.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Buy

The 15-minute technical read for Avalon Globocare Corp (NASDAQ-ALBT) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Buy

The 1-hour technical read for Avalon Globocare Corp (NASDAQ-ALBT) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Buy

The daily technical read for Avalon Globocare Corp (NASDAQ-ALBT) is currently Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for Avalon Globocare Corp (NASDAQ-ALBT) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for Avalon Globocare Corp (NASDAQ-ALBT) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

FAQ Fast Investor Answers

Avalon Globocare Corp (NASDAQ-ALBT) Stock FAQ

Data-supported answers about Avalon Globocare Corp (NASDAQ-ALBT), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$0.21
Estimated downside 29.1%
Valuation Rating
Overvalued
Estimated downside of 29.1%
Financial Health
Weak
Current financial-health read

The current fair value estimate for Avalon Globocare Corp (NASDAQ-ALBT) is $0.21. This implies an estimated downside of 29.1% versus the current market price.

Based on the current fair value estimate, the stock appears overvalued, with estimated downside of 29.1% versus the current market price.

The current financial health read for Avalon Globocare Corp (NASDAQ-ALBT) is Weak. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The latest available data indicates no current dividend yield for Avalon Globocare Corp (NASDAQ-ALBT).

The current market capitalization listed for Avalon Globocare Corp is 3.448 M.

The current enterprise value listed for Avalon Globocare Corp is 31.13 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Avalon Globocare Corp is NASDAQ-ALBT, and the stock is listed on NASDAQ.

Avalon Globocare Corp (NASDAQ-ALBT) is listed on NASDAQ.

The current debt-to-total-capital ratio listed for Avalon Globocare Corp is 4.5%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Avalon Globocare Corp is 89.5%. Free float helps investors understand how much of the share base is available for public trading.